Truxima 500 mg/50 mL (10 mg/mL) single-dose vial Images
Generic Name: rituximab
This medication has been identified as Truxima 500 mg/50 mL (10 mg/mL) single-dose vial. It is supplied by Teva Pharmaceuticals USA, Inc.
Truxima is used in the treatment of Granulomatosis with Polyangiitis; Diffuse Large B-Cell Lymphoma; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Non-Hodgkin's Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Truxima 500 mg/50 mL (10 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Truxima
- Generic Name
- rituximab
- Strength
- 500 mg/50 mL (10 mg/mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- Manufacturer
- Cephalon, Inc.
- National Drug Code (NDC)
- 63459-0104
More about Truxima (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Truxima drug information
- Truxima (Rituximab Intravenous) (Advanced Reading)
- Truxima (Rituximab-abbs Intravenous) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
